These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 178599)

  • 41. Cytomegalovirus infection in guinea pigs. IV. Maternal infection at different stages of gestation.
    Griffith BP; Hsiung GD
    J Infect Dis; 1980 Jun; 141(6):787-93. PubMed ID: 6248603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular localization of cytomegalovirus nucleic acids in guinea pig salivary glands by in situ hybridization.
    Griffith BP; Isom HC; Lavallee JT
    J Virol Methods; 1990 Feb; 27(2):145-57. PubMed ID: 2156878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.
    Schleiss MR; Bourne N; Bravo FJ; Jensen NJ; Bernstein DI
    J Virol Methods; 2003 Mar; 108(1):103-10. PubMed ID: 12565160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain and visceral involvement during congenital cytomegalovirus infection of guinea pigs.
    Griffith BP; Lucia HL; Hsiung GD
    Pediatr Res; 1982 Jun; 16(6):455-9. PubMed ID: 6285263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrastructural development of guinea pig cytomegalovirus in cultured guinea pig embryo cells.
    Fong CK; Bia F; Hsiung GD; Madore P; Chang PW
    J Gen Virol; 1979 Jan; 42(1):127-40. PubMed ID: 215704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demonstration of cytomegalovirus and retrovirus pseudotypes in cultured guinea pig cells.
    Lerner-Tung MB; Crouch JY; Hsiung GD
    Virology; 1991 Feb; 180(2):826-30. PubMed ID: 1703374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture.
    Nozawa N; Yamamoto Y; Fukui Y; Katano H; Tsutsui Y; Sato Y; Yamada S; Inami Y; Nakamura K; Yokoi M; Kurane I; Inoue N
    Virology; 2008 Sep; 379(1):45-54. PubMed ID: 18656220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model.
    Olejniczak MJ; Choi KY; McVoy MA; Cui X; Schleiss MR
    Virol J; 2011 Mar; 8():89. PubMed ID: 21371319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection.
    Hsiung GD; Choi YC; Bia F
    J Infect Dis; 1978 Aug; 138(2):191-6. PubMed ID: 210238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guinea pig cytomegalovirus: transplacental transmission. Brief report.
    Johnson KP; Connor WS
    Arch Virol; 1979; 59(3):263-7. PubMed ID: 222240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An animal model of neonatal cytomegalovirus infection.
    Bravo FJ; Bourne N; Schleiss MR; Bernstein DI
    Antiviral Res; 2003 Sep; 60(1):41-9. PubMed ID: 14516920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
    Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
    J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytomegaloviral infections in the guinea pig: experimental models for human disease.
    Bia FJ; Griffith BP; Fong CK; Hsiung GD
    Rev Infect Dis; 1983; 5(2):177-95. PubMed ID: 6302812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
    Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
    Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of GPCMV infected cells in vitro and in vivo with a monoclonal antibody.
    Jones CT; Keay SK; Swoveland PT
    J Virol Methods; 1994 Jul; 48(2-3):133-44. PubMed ID: 7989431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of cyclosporine on the pathogenesis of primary cytomegalovirus infection in the guinea pig.
    Bia FJ; Lucia HL; Bia MJ; Vine W; Tuttle A
    Intervirology; 1985; 24(3):154-65. PubMed ID: 2999030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune response to guinea pig cytomegalovirus polypeptides and cross reactivity with human cytomegalovirus.
    Kacica MA; Harrison CJ; Myers MG; Bernstein DI
    J Med Virol; 1990 Nov; 32(3):155-9. PubMed ID: 2177780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta.
    Hashimoto K; Yamada S; Katano H; Fukuchi S; Sato Y; Kato M; Yamaguchi T; Moriishi K; Inoue N
    Vaccine; 2013 Jun; 31(31):3199-205. PubMed ID: 23684839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination against transplacental cytomegalovirus transmission: vaccine reactivation and efficacy in guinea pigs.
    Bia FJ; Miller SA; Lucia HL; Griffith BP; Tarsio M; Hsiung GD
    J Infect Dis; 1984 Mar; 149(3):355-62. PubMed ID: 6325549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.